Home
About
Company Profile
History
Corporate Philosophy
Honors
Holding company
Social Responsibility
Factory Tour
Management Team
Investor Relations
Innovative R&D
R&D Team
R&D Conditions
Technology Platform
Research Collaboration
Research paper
R&D platform
Products under development
Sales & Marketing
Listed Products
Vaccination Site Notice
Batch Release Status
Pharmaceutical Representative Filing Information
Delivery Provider Disclosure
Mandatory Vaccine Insurance
Blog
Hundred Grams News
Employee Activities
Industry Information
Visualized Periodic Reports
Supervisory Management
GMP Implementation Status
Quality Management
Recall Status
Undergo inspection
Penalty Details
邮箱:bcht@bchtpharm.com
电话:400-8845-777
BLOG
03
2025/11
Baike Bio Exhibits in Frankfurt: Connecting to New Global Opportunities
28
2025/10
Baike Biotech Invited to Visit the Chongqing Municipal Center for Disease Prevention and Control, Aimed at Strengthening Strategic Cooperation between the Two Sides
20
“Foster a Rational Investment Mindset and Enhance Risk Awareness” — “2025 World Investor Week” Campaign
16
2025/09
“Safeguarding Financial Rights and Promoting a Better Life” — 2025 Financial Education Awareness Week
09
Phase I Clinical Trial of Baik Bio’s HSV-2 mRNA Vaccine Launched in Beijing!
29
2025/08
Understand Baike Bio’s Semi-Annual Report at a Glance